Explore 3 Stock Ideas & Industry Insights Download Free Report
Renalytix (LSE:RENX) is drawing attention following a company announcement dated 28 October 2026 concerning unaudited annual financial report. The diagnostics company published an unaudited report covering the twelve months ended 30 June 2026. This is a specific corporate development rather than evidence, by itself, …
Sareum Holdings (LSE:SAR) is drawing attention following a company announcement dated 28 October 2026 concerning retail offer outcome. The biotechnology company announced results of its WRAP offer. This is a specific corporate development rather than evidence, by itself, of a sustained change in market …
Investors are assessing how company-specific execution could influence earnings quality and future valuation.
Investors are assessing how company-specific execution could influence earnings quality and future valuation.
On 28 October 2026, Renalytix plc, listed in London as RENX, published unaudited results for the twelve months to 30 June 2026. The figures have been prepared under IAS 34 and are not statutory accounts. Renalytix is moving its accounting reference date to 31 …
GSK published its third-quarter results on 28 October 2026. Turnover for the quarter rose 4% to £8,887m, or 5% at constant exchange rates (CER). For the first nine months, turnover reached £24,925m, also up 4% (5% CER).
Smith & Nephew plc (LSE:SN.) remains on the radar as investors assess medical devices and orthopaedics against changing economic conditions.
• Investors are monitoring oncology pipeline, drug launches and operating guidance; the direction of those indicators will influence the next reassessment.
• Investors are monitoring vaccines, specialty medicines and research spending; the direction of those indicators will influence the next reassessment.
• Investors are monitoring organic sales, product innovation and cash conversion; the direction of those indicators will influence the next reassessment.
We use some essential cookies to make this site work. We also set analytics and marketing cookies, described below, to understand how you use the site and to measure our advertising. For more detailed information, see our Cookie Policy, Privacy Policy and Terms and Conditions.
These cookies are necessary for core functionality, such as security, your shopping cart, remembering your cookie choice, and your progress through a report or free-trial request you started. They always need to be on.
We use analytics cookies to understand how visitors use the site — the pages visited, time spent, and where visitors came from.
These help us measure how effective our advertising is, such as recording actions you take after clicking one of our ads. If you don't enable this, you may still see our ads, but they won't be measured this way.
Please wait processing your request...
You are not subscribed for this report, Want to See?
One of our sales representative will contact you soon!
Welcome to Kalkine!
Download Free Report
Hi! How can we help you today?
Loading…